Merck & Co., Inc. (MRK)
108.26
-0.93
(-0.85%)
USD |
NYSE |
Jan 13, 16:00
108.09
-0.17
(-0.16%)
After-Hours: 19:00
Merck Market Cap: 268.70B for Jan. 13, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 174.71B |
| Gilead Sciences, Inc. | 151.06B |
| Regeneron Pharmaceuticals, Inc. | 79.74B |
| Cidara Therapeutics, Inc. | 6.962B |
| Moderna, Inc. | 15.48B |
Market Cap Related Metrics
| PE Ratio | 14.32 |
| PS Ratio | 4.269 |
| PEG Ratio | 0.2455 |
| Price to Book Value | 5.182 |
| Price to Free Cash Flow | 20.90 |
| Price | 108.26 |
| Earnings Yield | 6.98% |
| PEGY Ratio | 0.2335 |
| Operating PE Ratio | 10.73 |
| Normalized PE Ratio | 12.67 |